Searched for
NAPO PHARMACEUTICALS
- We will break even in Central Eastern Europe next year: Glenn Saldanha, Chairman & MD, Glenmark PharmaceuticalsGlenn Saldanha, Chairman & MD, Glenmark Pharmaceuticals Ltd., in a chat to ET Now, talks about the company's performance and its future pla...
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
- Glenmark Pharmaceuticals to initiate filing for Crofelemer as Salix submits NDAGlenmark is going full steam ahead with the launch of Crofelemer post the issue of Napo Pharma's claim of termination of the deal.
- Napo termination will not impact company: GlenmarkIn an interview with ET Now, Glenn Saldanha, Chairman and Managing Director, Glenmark, gives his views on the company's strategies. Excerpt...
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.
- Glenmark achieves positive results for anti-diarrhoea moleculeGlenmark and Salix have also entered into a commercial supply agreement for Crofelemer active pharmaceutical ingredient.
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...
- Glenmark moves closer to HIV drug launchGlenmark Pharmaceuticals has completed the third phase of human trials of Crofelemer, a new drug to treat HIV-related diarrhoea that could ...
- We continue to remain optimistic about R&D space: Glen SaldanhaGlen Saldanha, Managing Director & CEO, Glenmark Pharmaceuticals speaks to ET Now. Excepts from the interview.
- Glenmark will launch Crofelemer in ROW countries by 2010Glenmark Pharmaceuticals Ltd has reported new development that should accelerate the launch of Crofelemer.
- Europe’s IPO market gives Wall St a run for its moneyThe lights may be going out on Wall Street, where for the first time since World War II bankers are on the verge of earning less from initi...
- Nicholas Piramal in pact with US co NapoDomestic pharmaceutical major Nicholas Piramal India has entered into a plant screening agreement with San Francisco-based Napo Pharmaceuti...
- Glenmark produces anti-diarrhoea ingredientGlenmark Pharmaceuticals Ltd on Friday said it has successfully produced active pharmaceutical ingredient (API), crofelemer, used for chron...
- Glenmark gets DGCI nod for drug trialGlenmark Pharmaceuticals Ltd today said it has received approval from the Drug Controller General of India (DCGI) to initiate phase II tria...
Load More- Napo termination will not impact company: Glenmark
